HER2estäjät
HER2estäjät, also known as HER2 inhibitors or HER2-targeted therapies, are a class of drugs used to treat certain types of cancer, most notably HER2-positive breast cancer. HER2, which stands for Human Epidermal growth factor Receptor 2, is a protein that can promote the growth of cancer cells. In some cancers, the HER2 gene is amplified, leading to an overproduction of the HER2 protein on the surface of cancer cells. This overabundance of HER2 can drive aggressive tumor growth.
HER2estäjät work by targeting this overexpressed HER2 protein. They can block the signaling pathways that HER2
The development of HER2estäjät has significantly improved the prognosis for patients with HER2-positive breast cancer, transforming